AtCor Medical Holdings Limited
Manufacturers - West Ryde, NSW
AtCor Medical is an Australian-headquartered company with its Corporate, Manufacturing, and R&D operations located in Sydney.
AtCor Medical is an Australian-headquartered company with its Corporate, Manufacturing, and R&D operations located in Sydney. An American subsidiary, AtCor Medical Inc (USA), has its US headquarters in Itasca, IL. AtCor Medical also has a European representative office, and markets its products through a network of national distributors in the major countries of the world.
The mission of AtCor Medical is to develop products for clinical use that can non-invasively assess the physiological status and the functioning of the cardiovascular system in humans. To do this, AtCor Medical works with leading international medical researchers in this field.
AtCor Medical's innovative product range, the SphygmoCor System, provides the following capabilities:
SphygmoCor CP Non-Invasive Aortic BP system, which non-invasively derives the calibrated BP waveform at the aortic root.
SphygmoCor CPV Pulse Wave Velocity system, which measures the velocity of the BP pressure wave between any two superficial artery sites (and so gives a measure of arterial stiffness).
SphygmoCor CPVH Heart Rate Variability system, which calculates the variability of the heart, including Valsalva and Standing Manoeuvre tests.
SphygmoCor CPM Non-Invasive Aortic BP Monitoring system, which monitors the ascending aortic waveform continuously, including real time trending of key central heart function parameters.
The SphygmoCor CP system complements the traditional cuff sphygmomanometer by non-invasively providing the following previously unavailable central clinical information:
- Evaluation of arterial stiffness and its clinical impact on the heart in increasing patient risk of heart failure, stroke and myocardial ischaemia.
- Coronary artery perfusion pressure throughout the cardiac cycle, including during the critical period of diastole when over 95% of subendocardial perfusion occurs.
- Left ventricular load, systolic “afterload”, and an index of myocardial oxygen demand.
- Pulse pressure in the ascending aorta which drives cerebral blood flow - and hence a better indicator of the risk of stroke.
- Central systolic pressure (as seen by the baro-receptors), often markedly different from the cuff value.
- Ejection duration and other cardiac cycle timing parameters.
- A powerful index of subendocardial viability giving an indication of cardiac reserve and exercise tolerance.
- Efficacy of drug therapies on key central heart function parameters.